Skip to main content

Table 2 Distribution of comorbid conditions or statin use in those without and with elevated hsCRP

From: Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathy

Categorical VariableshsCRP < 2 mg/L
(n = 9)
hsCRP ≥ 2 mg/L
(n = 16)
P-value
History of chemotherapy7 (78%)14 (88%)0.602
Cancer type (Breast vs. Lung)  1.000
 Breast cancer4 (44%)6 (38%) 
 Lung cancer5 (56%)10 (63%) 
History of anemia1 (11%)4 (25%)0.621
Obesity1 (11%)6 (38%)0.355
Hypertension4 (44%)10 (63%)0.434
Dyslipidemia5 (56%)5 (31%)0.397
Diabetes Mellitus1 (11%)5 (31%)0.364
Current Smoker2 (22%)4 (25%)1.000
Sedentary Lifestyle3 (33%)8 (50%)0.677
Statin Use3 (33%)5 (31%)1.000
Hormone therapy3 (33%)4 (25%)0.673
  1. Legend: Distribution of nominal variables expressed as Yes or No based on medical history and/or medication use. Proportion of those with the presence of categorical comorbid conditions, statin use, or hormone therapy use are reported as number (%). Obesity defined as a body mass index ≥30 kg per meter squared